Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Oct 5, 2021

Later deadlines: Nov 5, 2021, Jan 7, 2022

Grant amount: Unspecified amount

Fields of work: Infectious & Parasitic Diseases

Applicant type: Organizations

Funding uses: Non-clinical Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

This Funding Opportunity Announcement (FOA) invites applications to characterize antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands presented by classical and non-classical MHC class I and class II molecules, and to determine the contribution of these unique antigenic ligands to:

  • Protective immune responses to infectious pathogens and/or vaccines;
  • Pathogen-associated immune pathogenesis; and/or
  • In the induction/progression or prevention of immune-mediated diseases.

These studies may facilitate the development of novel tools and reagents to advance design of immune-based therapeutics and vaccines.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed November 15, 2018 and last updated November 15, 2018